Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.

Biotechnology

Facile Therapeutics

Facile Therapeutics' headquarters in Belmont, CA, United States

Marc Navre

Ciaran P. Kelly

Matthew Bogyo

Andrew Parratt

Sahil Khanna

Dan Lundberg

Peter Tam

Andrew McCandlish

Christine Murray

Ian Friedland

The Advisory Roles team at Facile Therapeutics plays a critical part in shaping the strategic direction of the company by providing expert guidance across various domains, including clinical development, scientific exploration, commercial strategies, funding opportunities, and regulatory compliance. This diverse team of advisors leverages their extensive experience to enhance clinical trial design for Ebselen and ensure its successful progression through the development pipeline while fostering partnerships and optimizing market readiness.

Advisory Roles

The Leadership Team at Facile Therapeutics is responsible for strategizing and guiding the company's clinical development efforts for Ebselen, ensuring its efficacy in preventing the recurrence of CDI. This team collaborates closely on scientific direction, regulatory compliance, and strategic partnerships, leveraging their extensive expertise to drive the Proof-of-Concept clinical trial toward successful outcomes.

Facile Therapeutics

Org chart

Board & advisors

Teams

Advisory Roles

Leadership Team

Offices

Facile Therapeutics

Org chart

Board & advisors

Teams

Advisory Roles

Leadership Team

Offices

Related companies